Beam Therapeutics, Inc. (BEAM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1247398,
    "name": "Beam Therapeutics, Inc.",
    "stock_name": "Beam Therapeutics, Inc.",
    "full_name": "Beam Therapeutics, Inc.",
    "name_url": "stocks-analysis/beam-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "28.91",
    "chg": 5.54,
    "chgp": "23.71%",
    "dir": 1,
    "prev_price": "23.37",
    "mcapval": "2,017.17",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US07373V1052",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.71 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/beam-therapeutics-inc-1247398-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Beam Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-beam-therapeutics-inc-technically-bullish-or-bearish-3673678",
        "imagepath": "",
        "date": "2025-11-05 11:22:32",
        "description": "As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the weekly RSI is bearish, suggesting some weakness. The Bollinger Bands are mildly bullish on both weekly and monthly time frames. Dow Theory shows a mildly bearish weekly outlook but a mildly bullish monthly perspective. \n\nIn terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -8.31% compared to the S&P 500's 16.30%, and a three-year return of -48.33% versus 76.66% for the index. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from the RSI and Dow Theory...."
      },
      {
        "title": "Beam Therapeutics Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beam-therapeutics-inc-technical-trend-changes-from-bullish-to-mildly-bullish-amid-stock-price-decline-3671413",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BeamTherapeutic_technicaldot_3671413.png",
        "date": "2025-11-04 16:11:45",
        "description": "Beam Therapeutics, Inc. has recently revised its evaluation amid changing market conditions. The stock, priced at $24.25, has seen a 5.76% return over the past year, contrasting with the S&P 500's 19.89%. Technical indicators present a mixed outlook, highlighting the company's challenges in a competitive landscape."
      },
      {
        "title": "Is Beam Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-beam-therapeutics-inc-technically-bullish-or-bearish-3670854",
        "imagepath": "",
        "date": "2025-11-04 11:34:00",
        "description": "As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on the weekly and a bullish stance on the monthly. Daily moving averages are bullish, but the KST shows a bearish monthly trend. Dow Theory presents a mildly bearish weekly view and a mildly bullish monthly view. The OBV is mildly bearish on both weekly and monthly time frames.\n\nIn terms of performance, Beam Therapeutics has underperformed the S&P 500 across multiple periods, with a year-to-date return of -2.22% compared to the S&P 500's 16.30%, and a three-year return of -44.90% versus the S&P 500's 76.66%. Overall, the current technical stance is mildly bullish, but the stock's performance relative to the benchmark suggests caution...."
      },
      {
        "title": "Is Beam Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-beam-therapeutics-inc-technically-bullish-or-bearish-3666460",
        "imagepath": "",
        "date": "2025-11-03 11:33:52",
        "description": "As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Daily moving averages are bullish, but the KST shows a bearish monthly trend. Dow Theory presents a mildly bearish weekly view and a mildly bullish monthly view, while the OBV is mildly bearish on both weekly and monthly time frames.\n\nIn terms of performance, Beam Therapeutics has underperformed the S&P 500 across multiple periods, with a 1-year return of 14.15% compared to the S&P's 19.89%, and a significant decline of 43.24% over the last 3 years versus the S&P's 76.66% gain. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from various indicators...."
      },
      {
        "title": "Is Beam Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-beam-therapeutics-inc-technically-bullish-or-bearish-3664574",
        "imagepath": "",
        "date": "2025-11-02 11:18:25",
        "description": "As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Daily moving averages are bullish, but the weekly KST is bullish while the monthly KST is bearish. Dow Theory shows a mildly bearish weekly trend and a mildly bullish monthly trend. The On-Balance Volume (OBV) is mildly bearish on both weekly and monthly time frames.\n\nIn terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of 0.85% compared to the S&P 500's 16.30%, and a one-year return of 14.15% against the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from various indicators...."
      },
      {
        "title": "Beam Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beam-therapeutics-inc-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-performance-gains-3649039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BeamTherapeutic_technicaldot_3649039.png",
        "date": "2025-10-27 15:49:57",
        "description": "Beam Therapeutics, Inc. has recently revised its evaluation amid current market conditions, with its stock priced at $27.96. Over the past year, the company has achieved a return of 26.57%, outperforming the S&P 500. However, its three-year return remains negative, indicating potential volatility and risks."
      },
      {
        "title": "Beam Therapeutics Stock Hits Day Low of $26.91 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beam-therapeutics-stock-hits-day-low-of-2691-amid-price-pressure-3641352",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BeamTherapeutic_priceRelatedfactors_3641352.png",
        "date": "2025-10-23 17:39:43",
        "description": "Beam Therapeutics, Inc. saw a notable decline in stock price today, contrasting with the stable performance of the S&P 500. Despite recent modest gains, the company's longer-term performance reveals significant declines over three and five years, alongside challenges such as negative net profit and declining sales."
      },
      {
        "title": "Beam Therapeutics, Inc. Experiences Evaluation Revision Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beam-therapeutics-inc-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-3640476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BeamTherapeutic_technicaldot_3640476.png",
        "date": "2025-10-20 15:27:51",
        "description": "Beam Therapeutics, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock price has shown slight movement, with notable volatility over the past year. Technical indicators present mixed signals, while performance comparisons reveal significant disparities against the S&P 500 over different time frames."
      },
      {
        "title": "Beam Therapeutics Stock Soars 7.44%, Hits Intraday High of $27.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beam-therapeutics-stock-soars-744-hits-intraday-high-of-2755-3608149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BeamTherapeutic_priceRelatedfactors_3608149.png",
        "date": "2025-10-09 21:03:08",
        "description": "Beam Therapeutics, Inc. has seen a significant stock price increase today, contrasting with a slight decline in the S&P 500. Despite recent gains, the company reported a substantial net profit loss and declining net sales, alongside negative cash flow and financial risks reflected in its operating metrics."
      }
    ],
    "total": 26,
    "sid": "1247398",
    "stock_news_url": "https://www.marketsmojo.com/news/beam-therapeutics-inc-1247398"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Beam Therapeutics, Inc. technically bullish or bearish?

2025-11-05 11:22:32

As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the weekly RSI is bearish, suggesting some weakness. The Bollinger Bands are mildly bullish on both weekly and monthly time frames. Dow Theory shows a mildly bearish weekly outlook but a mildly bullish monthly perspective. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -8.31% compared to the S&P 500's 16.30%, and a three-year return of -48.33% versus 76.66% for the index. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from the RSI and Dow Theory....

Beam Therapeutics Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-11-04 16:11:45

Beam Therapeutics, Inc. has recently revised its evaluation amid changing market conditions. The stock, priced at $24.25, has seen a 5.76% return over the past year, contrasting with the S&P 500's 19.89%. Technical indicators present a mixed outlook, highlighting the company's challenges in a competitive landscape.

Is Beam Therapeutics, Inc. technically bullish or bearish?

2025-11-04 11:34:00

As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on the weekly and a bullish stance on the monthly. Daily moving averages are bullish, but the KST shows a bearish monthly trend. Dow Theory presents a mildly bearish weekly view and a mildly bullish monthly view. The OBV is mildly bearish on both weekly and monthly time frames. In terms of performance, Beam Therapeutics has underperformed the S&P 500 across multiple periods, with a year-to-date return of -2.22% compared to the S&P 500's 16.30%, and a three-year return of -44.90% versus the S&P 500's 76.66%. Overall, the current technical stance is mildly bullish, but the stock's performance relative to the benchmark suggests caution....

Is Beam Therapeutics, Inc. technically bullish or bearish?

2025-11-03 11:33:52

As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Daily moving averages are bullish, but the KST shows a bearish monthly trend. Dow Theory presents a mildly bearish weekly view and a mildly bullish monthly view, while the OBV is mildly bearish on both weekly and monthly time frames. In terms of performance, Beam Therapeutics has underperformed the S&P 500 across multiple periods, with a 1-year return of 14.15% compared to the S&P's 19.89%, and a significant decline of 43.24% over the last 3 years versus the S&P's 76.66% gain. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from various indicators....

Is Beam Therapeutics, Inc. technically bullish or bearish?

2025-11-02 11:18:25

As of 31 October 2025, the technical trend for Beam Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Daily moving averages are bullish, but the weekly KST is bullish while the monthly KST is bearish. Dow Theory shows a mildly bearish weekly trend and a mildly bullish monthly trend. The On-Balance Volume (OBV) is mildly bearish on both weekly and monthly time frames. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of 0.85% compared to the S&P 500's 16.30%, and a one-year return of 14.15% against the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from various indicators....

Beam Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-27 15:49:57

Beam Therapeutics, Inc. has recently revised its evaluation amid current market conditions, with its stock priced at $27.96. Over the past year, the company has achieved a return of 26.57%, outperforming the S&P 500. However, its three-year return remains negative, indicating potential volatility and risks.

Beam Therapeutics Stock Hits Day Low of $26.91 Amid Price Pressure

2025-10-23 17:39:43

Beam Therapeutics, Inc. saw a notable decline in stock price today, contrasting with the stable performance of the S&P 500. Despite recent modest gains, the company's longer-term performance reveals significant declines over three and five years, alongside challenges such as negative net profit and declining sales.

Beam Therapeutics, Inc. Experiences Evaluation Revision Amid Mixed Market Signals

2025-10-20 15:27:51

Beam Therapeutics, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock price has shown slight movement, with notable volatility over the past year. Technical indicators present mixed signals, while performance comparisons reveal significant disparities against the S&P 500 over different time frames.

Beam Therapeutics Stock Soars 7.44%, Hits Intraday High of $27.55

2025-10-09 21:03:08

Beam Therapeutics, Inc. has seen a significant stock price increase today, contrasting with a slight decline in the S&P 500. Despite recent gains, the company reported a substantial net profit loss and declining net sales, alongside negative cash flow and financial risks reflected in its operating metrics.

View All News